MC
Med-Fine Capital
Venture CapitalActiveMed-Fine Capital is a Venture Capital firm focused on healthcare and bio-science industry.
16
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Med-Fine Capital.
Investment Thesis & Strategy
Med-Fine Capital invests in various stages of companies within the healthcare and bio-science industries. They seek innovative companies with the potential for significant growth and impact in the healthcare sector.
Investment Activity
Deals per year over the last 8 years
2
20152
20161
20174
20181
20190
20201
20211
2022Portfolio Companies
Selected investments from their portfolio of 16 companies
O
Obsidio
Biotech · Series A, 2022
V
Ventyx Biosciences
Biotech · Series B, 2021
I
Immusoft
Biotech · Series B, 2019
V
Vaxcyte
Biotech · Series B, 2018
C
Cerevel Therapeutics
Biotech · Series A, 2018
T
Triumvira Immunologics
Biotech · Series A, 2018
V
Vaxart
Biotech · Series B, 2018
L
Lyra Therapeutics
Biotech · Series B, 2017
R
Rani Therapeutics
Biotech · Series B, 2016
R
Rani Therapeutics
Biotech · Series B, 2016
A
Aeglea BioTherapeutics
Biotech · Series B, 2015
R
Revolution Medicines
Biotech · Series B, 2015
Frequently Asked Questions
Med-Fine Capital focuses on Series A, Series B, Series C+ stage investments.